MIELITEKO Lifestyle Intervention Study (MIELITEKO)

November 30, 2023 updated by: Tomi Mäki-Opas, University of Eastern Finland

Effective Promotion of Healthy Lifestyles, Mental Health and Wellbeing Among Disadvantaged Groups

Mental health problems cause individual, social and economic burden to the society. The mental health problems are among the highest levels in North Savo compared to the general Finnish population. The COVID-19 pandemic has emphasized the urgent need for tackling mental health problems and developing an effective and comprehensive approach to prevent mental health problems. The aim of this MIELITEKO pilot study is to test and develop an effective and comprehensive programme to prevent mental health problems and promote mental wellbeing among disadvantaged groups.

The pilot study is a multilayered intervention study with an RCT study design, which will be conducted in selected cities and areas in North Savo such as Kuopio, Iisalmi, Varkaus and Siilinjärvi. The disadvantaged groups of this study include people aged between 18 and 64 years who are unemployed or are outside the workforce. The participants are randomized 1:1 into intervention (N=250) and control groups (N=250). The intervention group will receive the multilayered intervention whereas the control group is assumed to continue with current health information and use of services "as usual" but remain in the waiting list. Multilayered intervention includes individual-level digital healthy lifestyle intervention, group-based healthy lifestyle intervention and green power intervention as well as mini-intervention for substance use.

The data collection of self-reported validated measure of health and wellbeing as well as relevant background factor will be conducted using digital and online survey tools in baseline (T0), and after 6 months (T1) and 12 months (T2) after the onset of the study from both intervention and control groups. Register data on the use of services and pharmaceuticals that will be gathered from the national registers at National Institute for Health and Welfare and Kela or from local registers administered by municipalities in North Savo. Pilot study will utilize quantitative and qualitative statistical analyses to evaluate the process, effects and effectiveness as well as cost-effectiveness of the intervention to promote mental health and wellbeing as well as to healthy lifestyles.

Study Overview

Study Type

Interventional

Enrollment (Actual)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Espoo, Finland, 02044
        • Technical Research Centre of Finland (VTT)
      • Helsinki, Finland, 24275
        • Buddy HealthCare Ltd Oy
      • Kuopio, Finland, 70201
        • Savonia University of Applied Sciences (SAVONIA)
      • Kuopio, Finland, 70600
        • City of Kuopio
    • Northern Savo
      • Kuopio, Northern Savo, Finland, 70211
        • University of Eastern Finland

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 64 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • age between 18 and 64 years
  • unemployed or outside the workforce (such as students)
  • living in Northern Savo

Exclusion Criteria:

- no access to personal mobile devices or to the internet

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1) Intervention group

Participants in this arm will be offered

  1. a digital individual-level intervention (Bit Habit) &
  2. group-based or individual-level healthy lifestyle and green power intervention
  3. a mini-intervention for substance use if their level of substance use is above certain risk level.
All participants in the intervention group receive access to the BitHabit app for the 1-year intervention period. The BitHabit app was designed in the StopDia project, and it aims to help its users to adopt healthier lifestyles and habits.The content and approach of the app is based on habit formation theories and the Self-Determination Theory. The app provides an extensive library of suggested lifestyle habits that was created according to lifestyle guidelines and recommendations. The habits are related to diet, physical activity, sleep, positive mood, stress management, smoking, and alcohol consumption. Users of the app select these habits from the library to their "shopping basket" to complete in their everyday life. The app also allows the users to report and monitor their performance and progress.
The group-based healthy lifestyle intervention is based on the Supportive Environment Theory (SET). The intervention is implemented in accordance with DiClemente and Prochaska's Stages-of-Change Model which is often used as framework for lifestyle change as well as Shazer and Berg's Solution Focused Brief Therapy. We expect participants to increase knowledge about healthy lifestyle choices and notice the beneficial effect of exercise, healthy diet and staying in nature. The intervention includes 12 to 16 hours of group activities during a period of 8 weeks. Interventions comprehend guided activities in nature, related to healthy relationship to food and exercise, as well as reflecting on shared experiences. In addition to group meetings, participants have access to material for mental well-being on an electronic learning environment.
The individual-level healthy lifestyle intervention follows the principles and theoretical background of the group-based intervention, but the intervention is carried out entirely on the electronic learning environment. The participants complete activities and exercises independently or with a friend in their own time.
The mini-intervention for substance use follows the principle of the ASSIST-linked brief intervention created by WHO. This brief intervention is a phone-call lasting 3 to 15 minutes and given to the participant according to their risk score calculated with the ASSIST questionnaire which is included in the baseline survey. The intervention includes presenting the participant with their test score and associated health problems related to their level of risk. Especially in primary health care context, brief intervention according to the ASSIST score has been found to be successful in moderating risk for substance use. The intervention is not intended as a stand-alone treatment and in cases where high risk substance use is detected, the professional should encourage the participant to seek specialized drug and alcohol assessment and treatment.
No Intervention: 2) Control group
The control group is assumed to continue with current health information and national recommendations for healthy lifestyle and use of services "as usual".

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Positive Mental Health (WEMWBS)
Time Frame: At baseline, 6 and 12 months after baseline

The definitive target of the healthy lifestyle intervention is an increase in measured positive mental health. The positive mental health of the respondents will be assessed with a self-reported validated measure of the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS).

The measure consists of 14 5-point Likert scale items, where the respondent states how often during the past two weeks they have felt as described in the proposed statement (none of the time, rarely, some of the time, often, all the time). The items cover positive affect (feelings of optimism, cheerfulness, relaxation), satisfying interpersonal relationships and positive functioning (energy, clear thinking, self-acceptance, personal development, competence and autonomy). All the items are scored positively according to the Likert scale value, giving a minimum score of 14 and maximum score of 70. Higher score indicates a higher level of mental well-being.

At baseline, 6 and 12 months after baseline
Change in Physical Activity
Time Frame: At baseline, 6 and 12 months after baseline

Physical activity is measured with assessment tools adopted from StopDia. In StopDia study, the questions regarding physical activity were modified from the Finrisk study, the Kuopio Ischaemic Heart Disease Risk Factor study and the International Physical Activity Questionnaire.

We inquire how often and with what duration the respondents carry out planned physical activity and exercise. We also inquire with similar questions the frequency of incidental activity, for example walking the stairs or gardening. Our outcome measure of physical activity is the total time used during a week for planned or incidental conditioning and everyday physical activities.

At baseline, 6 and 12 months after baseline
Change in Healthy Diet Index (HDI)
Time Frame: At baseline, 6 and 12 months after baseline
Diet quality and eating behaviors are assessed in the survey using the Healthy Diet Index (HDI). The Healthy Diet Index (HDI) was developed as part of the StopDia project to assess the quality of a diet. The index is a modification of the 18-Item Food Intake Questionnaire (D2D-FIQ). The index consists of seven domains: meal patterns, intake of grains, fruits and vegetables, fats, fish and meat, dairy and snacks and treats. The index is scored as a total score of the domains with a maximum score of 100 points.
At baseline, 6 and 12 months after baseline
Change in Alcohol, Smoking and Substance Involvement (ASSIST)
Time Frame: At baseline, 6 and 12 months after baseline
Alcohol consumption, smoking and other substance use are assessed in the survey with WHO's validated ASSIST questionnaire. In the questionnaire we inquire whether the respondent has used listed substances during their lifetime or in the past three months and how often they have had a strong urge to use them. We also inquire whether the respondent has faced health, social, legal or financial difficulties because of their substance use, their friends or relatives have raised concerns or they themselves have wished to stop using the substance. The measure for alcohol, smoking and substance abuse is calculated according to the principles of the ASSIST screening tool.
At baseline, 6 and 12 months after baseline
Change in Pittsburgh Sleep Quality Index (PSQI)
Time Frame: At baseline, 6 and 12 months after baseline
For assessment of sleep quality, we use the well-validated Pittsburgh Sleep Quality Index (PSQI). We inquire the typical times the respondent falls asleep and wakes up on weekdays and weekends. We also ask them how easy it is for them to fall asleep and if they wake up during the night. Additionally, we survey different symptoms and effects of sleep dysfunction according to the Pittsburg Sleep Quality questionnaire. Our outcome measure for sleep quality is the global PSQI score.
At baseline, 6 and 12 months after baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Beck Depression Inventory (BDI 21)
Time Frame: At baseline, 6 and 12 months after baseline
Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression. Higher score means higher depression.
At baseline, 6 and 12 months after baseline
Beck Anxiety Inventory (BAI 21)
Time Frame: At baseline, 6 and 12 months after baseline
The Beck Anxiety Inventory (BAI) consists of 21 self-reported items (four-point scale) used to assess the intensity of physical and cognitive anxiety symptoms during the past week. Higher score means higher anxiety.
At baseline, 6 and 12 months after baseline
Psychotic symptoms
Time Frame: At baseline, 6 and 12 months after baseline
Psychotic-like experiences, Scale: Youth experiences and Health, Short version, developed by the Finnish Institute for Health and Welfare (THL), higher scores to worse to outcome.
At baseline, 6 and 12 months after baseline
Social inclusion scale, THL
Time Frame: At baseline, 6 and 12 months after baseline
Survey instrument to assess self-reported experiences of social inclusion, summary score from individual items, scaled to 0-100, higher score means higher inclusion.
At baseline, 6 and 12 months after baseline
Resilience Scale (RS-14)
Time Frame: At baseline, 6 and 12 months after baseline
Finnish version of the resilience scale (RS-14), shortened version of RS developed by Wagnild & Young 1993. Include 14 individual items, total score range from 14-98, higher score means higher resilience.
At baseline, 6 and 12 months after baseline
Capabilities (CA)
Time Frame: At baseline, 6 and 12 months after baseline
Finnish versio of the capabilities scale (CA), developed by the Anand et al 2005, include 7 individual items plus summary question, scale from 1 to 7, total score is calculated by summarizing the 7 individual items, higher score means better capabilities.
At baseline, 6 and 12 months after baseline
UCLA loneliness scale
Time Frame: At baseline, 6 and 12 months after baseline
Finnish version of the UCLA loneliness scale (Russell et al 1996), that measure Subjective feelings of loneliness as well as feelings of social isolation. Short-version, summary score in which higher scores means severe loneliness.
At baseline, 6 and 12 months after baseline
Social cohesion
Time Frame: At baseline, 6 and 12 months after baseline
General instrument to measure trust to public institutes (government, policy, health and social care, ) and other people with a scale from 1 (low) to 5 (high trust). Summary score of these individual items presented general trust (social cohesion) to public institutes or other people. Higher score presents higher social cohesion.
At baseline, 6 and 12 months after baseline
The Alcohol Use Disorders Identification Test (AUDIT-C)
Time Frame: At baseline, 6 and 12 months after baseline
The AUDIT-C measures whether the person's drinking is affecting his or her health and safety. Scale is scored between 0 (no use) and 12. Higher the score higher the more likely drinking is affecting health and safety of the person.
At baseline, 6 and 12 months after baseline
Nature relationship
Time Frame: At baseline, 6 and 12 months after baseline
perceived wellbeing and health effects of the nature, including individual items on health, positive feelings, stress, importance of nature, as well as how often spends time in nature and how much per each visit. Scale for each is Likert-5, daily-once o months, not spending time - hour or more
At baseline, 6 and 12 months after baseline
Perceived health and illnesses
Time Frame: At baseline, 6 and 12 months after baseline
persons general perception of their health and illnesses, scale (very food) 1-5 (very poor)
At baseline, 6 and 12 months after baseline
Diseases diagnosed by a doctor
Time Frame: At baseline, 6 and 12 months after baseline
A long list of various diseases diagnosed by a doctor, scale yes or no.
At baseline, 6 and 12 months after baseline
Self-reported use of health and social care
Time Frame: At baseline, 6 and 12 months after baseline
Use of various health and social services during the last 12 months, scale: yes or no, how many times
At baseline, 6 and 12 months after baseline
Register-based information of health and social service use and costs
Time Frame: At baseline, 6 and 12 months after baseline
National and local register information of the use of social and health services as well as medicines will be linked to the data, including use and costs of the services and medicines
At baseline, 6 and 12 months after baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sociodemographic factors
Time Frame: At baseline, 6 and 12 months after baseline
gender, age, marital status, education, housing, household income, size of the family, main economic activity, household income, loans, financial difficulties, reemployment possibilities
At baseline, 6 and 12 months after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 24, 2022

Primary Completion (Actual)

August 31, 2023

Study Completion (Actual)

September 30, 2023

Study Registration Dates

First Submitted

March 25, 2022

First Submitted That Met QC Criteria

May 11, 2022

First Posted (Actual)

May 17, 2022

Study Record Updates

Last Update Posted (Actual)

December 7, 2023

Last Update Submitted That Met QC Criteria

November 30, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All suitable metadata produced by this study will be made openly available to the scientific community and society for example from the Finnish Social Science Data Archive (FSD). No Individual Participant Data (PDF) will be made openly available.

IPD Sharing Time Frame

After the planned study has ended.

IPD Sharing Access Criteria

For research purposes, persons interested to use the data can contact PI for research collaboration.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health

3
Subscribe